PersonInvestorFounder
Samir Kaul
Samir Kaul is a Founding General Partner at Khosla Ventures who cut the first and largest check into OpenAI before the world knew what a language model could do. A former genomics researcher who co-authored the landmark Arabidopsis genome paper in Nature, he brings a rare scientist's rigor to venture capital - betting on technical risk, not market risk. His portfolio spans Guardant Health, Nutanix, Impossible Foods, and Varda Space Industries, and his philosophy is deceptively simple: find visionary founders attacking large markets with real technology.
venture capitalkhosla venturesopenaibiotechdeep techai
